GxP Insights

Displaying 1 - 4 of 18

GxP Insights
GxP Insights: Capital vs. Capability: Nicholas Bonavita on Getting a $30 Million Sterile Manufacturing Expansion Off the Ground
With a career built across some of the most demanding environments in life sciences manufact...

By Harry Reeve September 30th, 2026
GxP Insights
GxP Insights: Dr. Sandra Smyth on Life Inside One of the Most Complex System Implementations in U.S. Pharma
With almost three decades of experience across regulated industries, Dr. Sandra Smyth&n...

By Hamish Corson August 19th, 2026
GxP Insights
GxP Insights: FDA Form 483s: What the Surge in Enforcement Means for U.S. Drug Manufacturers
Welcome to our monthly industry insights newsletter, tailored for professionals in Medical D...

By David Dolman June 8th, 2026
GxP Insights
GxP Insights: The Purolea Warning Letter: What It Means for AI in GxP Manufacturing
Welcome to our monthly industry insights newsletter, tailored for professionals in Medical D...

By David Dolman May 5th, 2026

Displaying 1 - 4 of 18

Category: Industry Insights (30); Candidates (6); i-Pharm News (10); Case Study (11); GxP Engagement (11); GxP Insights (18)